Search Results

Endocrine Therapies and QTc Prolongation

Authors: Gonzalez, Claudio D.; de Sereday, Martha; Sinay, Isaac; Santoro, Silvina

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 79-84(6)

Publisher: Bentham Science Publishers

Editorial [Hot Topic: The Medicinal Chemistry of New Agents to Treat Obesity (Guest Editor: Jinhwa Lee)]

Author: Lee, Jinhwa

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 6, April 2009 , pp. 465-465(1)

Publisher: Bentham Science Publishers

Anti-obesity Agents: A Focused Review on the Structural Classification of Therapeutic Entities

Authors: Oh, Sangmi; Kim, Koon S.; Chung, Young S.u.n.; Shong, Minho; Park, Seung B.u.m.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 6, April 2009 , pp. 466-481(16)

Publisher: Bentham Science Publishers

The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents

Authors: Lee, Hyeon-Kyu; Choi, Eun B.; Pak, Chwang S.i.e.k.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 6, April 2009 , pp. 482-503(22)

Publisher: Bentham Science Publishers

Promising Strategies for Obesity Pharmacotherapy: Melanocortin-4 (MC- 4) Receptor Agonists and Melanin Concentrating Hormone (MCH) Receptor-1 Antagonists

Authors: Jeon, Moon-Kook; Cheon, Hyae G.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 6, April 2009 , pp. 504-538(35)

Publisher: Bentham Science Publishers

Computer-Aided Identification of Ligands for GPCR Anti-Obesity Targets

Authors: Min, Kyung H.; Yoo, Jakyung; Park, Hyun-Ju

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 6, April 2009 , pp. 539-553(15)

Publisher: Bentham Science Publishers

Tesofensine - a novel potent weight loss medicine

Author: Doggrell, Sheila A

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 7, July 2009 , pp. 1043-1046(4)

Publisher: Informa Healthcare

Potential Risks Associated with the Use of Herbal Anti-Obesity Products

Author: Chan, Thomas Y.K.

Source: Drug Safety, Volume 32, Number 6, 21 May 2009 , pp. 453-456(4)

Publisher: Adis International

Current and Future Drugs for Appetite Regulation and Obesity Treatment

Authors: Lorenzo, Iughetti; Rossella, Berri; Mariachiara, China; Barbara, Predieri

Source: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Volume 3, Number 2, June 2009 , pp. 102-128(27)

Publisher: Bentham Science Publishers

Antihypertensive therapy, new-onset diabetes, and cardiovascular disease

Author: Basile, J. N.

Source: International Journal of Clinical Practice, Volume 63, Number 4, April 2009 , pp. 656-666(11)

Publisher: Blackwell Publishing

Recent Advances in Obesity Pharmacotherapy

Authors: Mayer, Marcos A.; Hocht, Christian; Puyo, Ana; Taira, Carlos A.

Source: Current Clinical Pharmacology, Volume 4, Number 1, January 2009 , pp. 53-61(9)

Publisher: Bentham Science Publishers

Obesity: Pathophysiology and Clinical Management

Authors: Gurevich-Panigrahi, Tatiana; Panigrahi, Soumya; Wiechec, Emilia; Los, Marek

Source: Current Medicinal Chemistry, Volume 16, Number 4, February 2009 , pp. 506-521(16)

Publisher: Bentham Science Publishers

A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease

Authors: Cook, Sharlene A.; MacLaughlin, Helen; Macdougall, Iain C.

Source: Nephrology Dialysis Transplantation, Volume 23, Number 1, 11 January 2008 , pp. 263-268(6)

Publisher: Oxford University Press

Endocannabinoids and the Neurochemistry of Gluttony

Author: Kirkham, Tim

Source: Journal of Neuroendocrinology, Volume 20, Number 9, September 2008 , pp. 1099-1100(2)

Publisher: Blackwell Publishing

The differing mechanisms of action of anti-obesity agents determines their varying impact on the cardiovascular system

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 8, August 2008 , pp. 19-21(3)

Publisher: Adis International

The future of obesity: new drugs versus lifestyle interventions

Author: Scheen, Andr J

Source: Expert Opinion on Investigational Drugs, Volume 17, Number 3, March 2008 , pp. 263-267(5)

Publisher: Informa Healthcare

Development of anti-obesity agents: drugs that target neuropeptide and neurotransmitter systems

Author: Fong, Tung M

Source: Expert Opinion on Investigational Drugs, Volume 17, Number 3, March 2008 , pp. 321-325(5)

Publisher: Informa Healthcare

Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy

Author: Atkinson, T. J.

Source: Obesity Reviews, Volume 9, Number 2, March 2008 , pp. 108-120(13)

Publisher: Blackwell Publishing

Management of type 2 diabetes in the obese patient: current concerns and emerging therapies

Author: Krentz, Andrew J.

Source: Current Medical Research and Opinion, Volume 24, Number 2, February 2008 , pp. 401-417(17)

Publisher: Informa Healthcare

Obesity: Overview & Management

Authors: Bhandari, Kalpana; Srivastava, Shipra

Source: Current Bioactive Compounds, Volume 3, Number 4, December 2007 , pp. 278-290(13)

Publisher: Bentham Science Publishers